Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Discontinued products: April 2014

12 April 2014

Donepezil

Donepezil tablets 10mg, 2 x 14,  were discontinued by Pfizer on 1 April 2014.

Epaxal

Epaxal (hepatitis A vaccine) and Inflexal V (influenza vaccine) will be discontinued by Crucell, part of Janssen, during 2014. Vivotif (typhoid vaccine) will continue to be available until at least the end of April 2014, after which Vivotif will also be discontinued if “divestment” is not possible. 

Frusene

Frusene (triamterene, furosemide; Orion) T100 will be discontinued when current stocks are exhausted. The T56 pack is still available.

Sinepin

Sinepin (doxepin hydrochloride) capsules 25mg and 50mg in packs of 28 are being discontinued by Marlborough Pharma on 18 April 2014. A generic version of the medicine is available through Sovereign Medical on 01268 535230. 

05 April 2014

Gopten

Abbott has discontinued Gopten (trandolapril) capsules 14 x 0.5mg, and 28 x 1mg, 2mg and 4mg. 

Sanomigran

Novartis has discontinued Sanomigran Elixir and Sanomigran tablets 0.5mg following the closure of its UK manufacturing site. Stocks of the elixir are already exhausted. The company expects that stocks of the tablets will last until July 2014. Sanomigran tablets 1.5mg are still available.

 

 

 

 

 

Citation: The Pharmaceutical Journal URI: 20065493

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.